Non-Small Cell Lung Carcinoma

DBCOND0030527NeoplasmsRespiratory Tract Diseases

Non-Small Cell Lung Carcinoma is the indication for 3 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Non-Small Cell Lung Carcinoma (NSCLC) · Non Small Cell Carcinoma of the Lung · Non-small Cell Lung Carcinoma (Adenocarcinoma) · NSCLC (Non-small Cell Lung Carcinoma) · NSCLC, Non-small-cell Lung Carcinoma
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT000997468

What you can answer from here — as of October 26, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
560Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Non-Small Cell Lung Carcinoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In